Abstract Body

Background: Although combinational antiretroviral therapy (ART) has been an effective tool in controlling replication of the Human Immunodeficiency Virus (HIV), ART has not been completely effective to suppress neurological complications. While some cases of cognitive impairment can be attributed to ART failure, many individuals develop HIV-Associated Neurocognitive Disorders (HAND) with stable ART, little or no detectable viral load, and CD4 counts in the normal range. HIV-infection and ART are each associated with disturbances in peripheral and central bioenergetics. Although brain imaging studies have shown the importance of metabolic abnormalities in HAND, the underlying bioenergetic pathways modified by infection and ART are not well understood.

Methods: The metabolic composition of CSF was analysed using 1H-NMR spectroscopy, which focused on energy metabolites. Metabolic biomarkers for cognitive states were identified using multivariate PLS regression modelling of the acquired spectra, combined with non-parametric analyses of metabolites with clinical features.

Results: Multivariate modeling and cross-validated recursive partitioning identified several energy metabolites that, when combined with clinical variables, classified subjects based on change in neurocognitive states. Prognostic identification for worsening was achieved with 4 features that included 1 clinical measure (no change in a detectable plasma viral load), and 3 metabolites (elevated citrate and acetate; decreased creatine), to produce a model with a predictive accuracy of 92%, sensitivity of 88%, and 96% specificity. Prognosis for improvement contained 7 features that included 2 clinical measures (first visit age <47 years, new or continued use of antiretrovirals), and 5 metabolites (elevated glutamine and glucose; decreased myo-inositol, b-glucose, and creatinine) to generate a model with a predictive accuracy of 92%, sensitivity of 100% and specificity of 84%.

Conclusions: These CSF metabolic results suggest that worsening cognitive status in HIV-infected patients is associated with increased aerobic glycolysis, and improvements in cognitive status are associated with a shift to anaerobic glycolysis. Dietary, lifestyle and pharmacologic interventions that promote anaerobic glycolysis may protect the brain in setting of HIV infection with ART.